Nephrocare Healt

  • Market Cap: Small Cap
  • Industry: Healthcare Services
  • ISIN: INE428V01029
  • NSEID: NEPHROPLUS
  • BSEID: 544647
INR
529.05
-1.35 (-0.25%)
BSENSE

Feb 09

BSE+NSE Vol: 26.56 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationUpcoming Result: Nephrocare Healt will declare its result soon on 10 Feb 2026
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

26.56 k (-56.26%) Volume

Shareholding (Dec 2025)

FII

9.30%

Held by 20 FIIs

DII

3.48%

Held by 9 DIIs

Promoter

63.85%

Which are the latest news on Nephrocare Healt?

08-Feb-2026
No latest news for Nephrocare Healt found.

Why is Nephrocare Health Services Ltd falling/rising?

08-Feb-2026

As of 08-Feb, Nephrocare Health Services Ltd's stock price is rising to Rs 530.40, driven by strong performance relative to its sector and moving averages, despite a significant drop in investor participation. The stock has gained 13.03% year-to-date, outperforming the benchmark Sensex.

As of 08-Feb, Nephrocare Health Services Ltd's stock price is rising, currently at Rs 530.40, reflecting a change of Rs 12.25 or 2.36%. This upward movement can be attributed to several factors. The stock has outperformed its sector by 2.29% today and has reached an intraday high of Rs 536.45, which is only 1.56% away from its 52-week high of Rs 538.7. Additionally, Nephrocare is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong upward trend in its price performance.<BR><BR>Over the past month, the stock has increased by 7.78%, while the benchmark Sensex has declined by 1.74%, further highlighting its relative strength. Year-to-date, Nephrocare has gained 13.03%, contrasting with a 1.92% drop in the Sensex. However, it is worth noting that there has been a significant decrease in investor participation, with delivery volume dropping by 62.22% against the 5-day average. Despite this decline in participation, the stock's liquidity remains adequate for trading. Overall, the combination of strong price performance relative to benchmarks and moving averages supports the observed rise in Nephrocare Health Services Ltd's stock price.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Healthcare Services

stock-summary
Market cap

INR 5,309 Cr (Small Cap)

stock-summary
P/E

79.00

stock-summary
Industry P/E

57

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.02

stock-summary
Return on Equity

11.74%

stock-summary
Price to Book

9.31

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Icon
Company does not have enough history
Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Shareholder Meeting / Postal Ballot-Scrutinizers Report

07-Feb-2026 | Source : BSE

Voting results under Regulation 44(3) of SEBI (LODR) Regulations 2015 along with Scrutinizers Report

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

30-Jan-2026 | Source : BSE

Pursuant to Regulation 30 of the Listing Regulations we hereby inform you that the Company has scheduled an Investor Result Conference Call on Wednesday 11th February 2026 at 16:00 (Indian Standard Time) to discuss the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended 31st December 2025. A copy of the invitation is attached for your information.

Board Meeting Intimation for Considering And Approving Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended 31St December 2025.

30-Jan-2026 | Source : BSE

Nephrocare Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2026 inter alia to consider and approve the unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended 31st December 2025.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

10 Feb 2026

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
4.40
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
17.40%
ROCE (avg)
4.47%
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
79
Industry P/E
57
Price to Book Value
9.31
EV to EBIT
56.42
EV to EBITDA
31.88
EV to Capital Employed
9.45
EV to Sales
7.03
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
16.74%
ROE (Latest)
11.74%

Technicals key factors

Indicator
Weekly
Monthly
Icon
No records
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 7 Schemes (3.1%)

FIIs

Held by 20 FIIs (9.3%)

Promoter with highest holding

Edoras Investment Holdings Pte Ltd (28.3%)

Highest Public shareholder

Investcorp India Investments Holding Limited (6.29%)

Individual Investors Holdings

5.92%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Nephrocare Healt"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Nephrocare Healt"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Nephrocare Healt"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "alert": "No Annual Results declared by Nephrocare Healt"
  }
]
stock-summaryCompany CV
About Nephrocare Health Services Ltd stock-summary
stock-summary
Nephrocare Health Services Ltd
Small Cap
Healthcare Services
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available